<DOC>
	<DOCNO>NCT02007928</DOCNO>
	<brief_summary>We propose prospective multicenter study , whose originality lie inclusion naive child adolescent population . Its purpose evaluate incidence adverse event relate use l antipsychotic drug child adolescent history take drug . The inclusion criterion : ( 1 ) male female inpatient , ( 2 ) age 6 18 year , ( 3 ) require antipsychotic treatment , ( 4 ) receive antipsychotic drug le 28 day without take antipsychotic history antipsychotic maximum period three consecutive month discontinue least 6 month . Therapeutic monitoring 12 month study period include clinical assessment laboratory test . These assessment perform treatment ( inclusion ) , 1 , 3 , 6 , 9 , 12 month introduction antipsychotic drug .</brief_summary>
	<brief_title>Assessment Adverse Events Naive Pediatric Population Treated With Antipsychotic</brief_title>
	<detailed_description>prospective multicenter study , whose originality lie inclusion naive child adolescent population</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Dissociative Disorders</mesh_term>
	<mesh_term>Conversion Disorder</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>Male female patient Aged 6 18 year In antipsychotic treatment indicate Who never treat antipsychotic medication ( metoclopramide ( PrimperanÂ® ) pediatric indication ) history antipsychotic maximum period three consecutive month discontinue least 6 month . . The noninclusion criterion : Any The exclusion criterion : Refusal withdrawal consent patient his/her parent .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>